Highlights

 

Mark Your Calendar for the 2013 GU Cancers Symposium

The Genitourinary Cancers Symposium (February 14-16, 2013 in Orlando, Florida) is an opportunity to collaborate on the latest clinical and scientific strategies in management of Genitourinary (GU) cancers in a small, forum setting facilitated by the top experts in the field. The 2013 Symposium is designed to offer attendees the opportunity to learn about the latest clinical and scientific strategies in screening, evaluation, and management of GU cancers through insightful, informative educational and scientific sessions. 

 

 
 
The 2012 Genitourinary Cancers Symposium is supported by:
 
Astellas  ♦  AVEO Pharmaceuticals, Inc.  ♦  Medivation  ♦  Amgen  ♦  Teva Pharmaceuticals   
 
  Bayer Healthcare Pharmaceuticals Inc.  ♦  Janssen Biotech, Inc.  ♦  Millennium: The Takeda Oncology Company  ♦  Pfizer            
 
 

 

WebsiteFeedback